CWM
BIO icon

CIBC World Markets’s Bio-Rad Laboratories Class A BIO Stock Holding History

CIBC World Markets’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-887
Closed -$216K – 1600
2025
Q1 		$216K Buy
887
+10
+1% +$3.01K ﹤0.01% 1431
2024
Q4 		$288K Sell
877
-284
-24% -$96.4K ﹤0.01% 952
2024
Q3 		$388K Sell
1,161
-1,432
-55% -$455K ﹤0.01% 694
2024
Q2 		$708K Buy
2,593
+493
+23% +$143K ﹤0.01% 629
2024
Q1 		$726K Sell
2,100
-607
-22% -$200K ﹤0.01% 681
2023
Q4 		$874K Buy
2,707
+1,554
+135% +$487K ﹤0.01% 621
2023
Q3 		$413K Sell
1,153
-1,354
-54% -$522K ﹤0.01% 586
2023
Q2 		$950K Buy
2,507
+1,418
+130% +$577K 0.01% 555
2023
Q1 		$522K Sell
1,089
-1,443
-57% -$675K 0.01% 581
2022
Q4 		$1.06M Buy
+2,532
New +$1.02M 0.01% 586
2022
Q3 		– Sell
-1,511
Closed -$748K – 565
2022
Q2 		$748K Sell
1,511
-2,937
-66% -$1.53M 0.01% 568
2022
Q1 		$2.5M Buy
4,448
+373
+9% +$225K 0.02% 372
2021
Q4 		$3.08M Sell
4,075
-775
-16% -$580K 0.02% 334
2021
Q3 		$3.62M Buy
4,850
+3,354
+224% +$2.51M 0.02% 341
2021
Q2 		$964K Sell
1,496
-562
-27% -$342K 0.01% 542
2021
Q1 		$1.18M Sell
2,058
-1,908
-48% -$1.13M 0.01% 567
2020
Q4 		$2.31M Buy
3,966
+1,388
+54% +$790K 0.01% 538
2020
Q3 		$1.33M Buy
2,578
+474
+23% +$240K 0.01% 494
2020
Q2 		$950K Buy
+2,104
New +$928K 0.01% 501
2020
Q1 		– Sell
-18,475
Closed -$6.84M – 602
2019
Q4 		$6.84M Buy
+18,475
New +$6.51M 0.04% 331
2019
Q3 		– Sell
-1,338
Closed -$418K – 664
2019
Q2 		$418K Sell
1,338
-70,436
-98% -$21.1M ﹤0.01% 664
2019
Q1 		$21.9M Buy
71,774
+59,574
+488% +$16.1M 0.18% 125
2018
Q4 		$2.83M Buy
+12,200
New +$3.27M 0.03% 420
2015
Q3 		– Sell
-300,000
Closed -$45.2M – 247
2015
Q2 		$45.2M Buy
+300,000
New +$42.9M 1.43% 16

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $8.09B AUM 21.95% 1-Year Est. Return

CIBC World Markets's BIO Position: Q2 2025 in Review

CIBC World Markets sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 887 shares — an estimated $216K sold.

CIBC World Markets first reported a position in BIO in Q2 2015 and held it in 24 quarters. The position peaked at $45.2M in Q2 2015. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

  • CIBC World Markets reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
  • CIBC World Markets sold 887 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $216K.
  • CIBC World Markets first reported a position in Bio-Rad Laboratories Class A in Q2 2015 and held it in 24 quarters.
  • CIBC World Markets's Bio-Rad Laboratories Class A position peaked at $45.2M in Q2 2015.
  • 384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.